Abstract:
Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), however the exact mechanisms remain incompletely understood. Here we demonstrate that macrophage scavenger receptor 1 (MSR1) is associated with the occurrence of hepatic lipid-laden foamy macrophages and correlates with the degree of steatosis and 5 steatohepatitis in a large cohort of NAFLD patients. Mice lacking Msr1 are protected against high fat diet-induced metabolic disorder, showing less hepatic inflammation and fibrosis, reduced circulating fatty acids, increased lipid storage in the adipocytes and improved glucose tolerance.
Moreover, MSR1 triggers diet-induced JNK-mediated inflammatory activation of macrophages independent of lipopolysaccharide. Taken together, our data suggest a critical role for MSR1 in 10 lipid homeostasis and a potential therapeutic target for the treatment of NAFLD.
One Sentence Summary:
The immunometabolic role of MSR1 in human NAFLD. 15 
Main Text:
With the increasing prevalence of obesity, non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease globally (1). NAFLD is characterised by excessive hepatic triglyceride accumulation and represents a series of diseased states ranging from isolated steatosis (non-alcoholic fatty liver, NAFL) to non-alcoholic steatohepatitis (NASH), identified by the 5 presence of necro-inflammation and hepatocyte ballooning, with varying degrees of fibrosis.
NAFLD is strongly linked with metabolic syndrome, i.e. dyslipidemia, hypertension, obesity and type 2 diabetes mellitus (T2DM), and currently affects 20 to 30% of the global population (2) . Importantly, not all patients progress from NAFL to NASH and although gene signatures of more advanced fibrosing-steatohepatitis have been identified, the exact pathogenic pathways involved 10 in the initiating phases of the disease, especially the transition from NAFL to NASH, are not fully understood (3) .
Growing evidence supports the view that Kupffer cells, the endogenous hepatic macrophages, are initiators of inflammation and hence contribute to NAFLD development, while recruited monocyte-derived macrophages play a crucial role in the disease progression (4) (5) (6) . Hepatic 15 macrophages are responsive to a variety of stimuli including bacterial endotoxins (lipopolysaccharide, LPS) but also free fatty acids (FFAs) or cholesterol (4) (5) (6) . However, molecular mechanisms underlying hepatic macrophage activation remain poorly understood.
Recent data show that pro-inflammatory activation of macrophages by saturated fatty acids (SFA) is independent of Toll-like receptor 4, yet the receptor that is responsible is still not known (7) . 20 Recently, we have shown that in vitro activation of the phagocytic receptor, macrophage scavenger receptor 1 (MSR1, also known as SR-A or CD204), results in pro-inflammatory macrophage polarisation through JNK activation (8) . MSR1 is a key macrophage receptor for the clearance of circulating lipoproteins and has been implicated in atherogenesis (9, 10) . We therefore hypothesised that MSR1 might be involved in inflammatory responses in the context of lipid 25 overload during obesity-induced NAFLD.
To investigate the impact of MSR1 on NAFLD, we first analysed MSR1 gene expression in a cohort of 170 histologically characterised human liver biopsies using nanoString®. The cohort was stratified according to histopathological disease grade and stage, i.e. NAFL and NASH with fibrosis ranging from F0 to F4 (Table S1 ). The analysis revealed a significant increase of MSR1 30 gene expression in NASH compared to NAFL, indicating a positive correlation with the active 5 inflammatory form of the disease (Fig. 1a) . This observation was supported by a significant correlation between MSR1 mRNA levels and steatosis grade (r=0.29, p=0.0001), hepatocyte ballooning (r=0.22, p<0.01) and lobular inflammation (r=0.24, p<0.01), while there was no correlation with stages of hepatic fibrosis indicating that MSR1 mRNA levels are strongly linked to steatohepatitis activity rather than wound healing per se ( Fig. 1b and Fig. S1a ) (11) . 5 Furthermore, MSR1 levels positively correlated with serum levels of alanine transaminase, ALT (r=0.31, p=0.0001), and aspartate transaminase, AST (r=0.32, p<0.0001) ( Fig. S1b ). quantification of immunopositive cells in the scWAT was stratified based on the presence of NAFLD (n=20). Data are presented as mean ± SEM (Mann-Whitney-U test, * p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, ns: non-significant). Scale bars 200µm.
Fig. 1. Macrophage Scavenger Receptor 1 (MSR1) expression in human non-alcoholic fatty liver
Histopathological analysis of human NAFLD liver biopsies showed that MSR1 was predominantly 5 expressed in resident liver macrophages rather than infiltrating monocyte-derived macrophages located in the portal tract, as visualised by the CD68 immunostaining ( Fig. 1c and Fig. S2 ) (12, 13) . Notably, MSR1 immunopositivity was seen in lipid-laden foamy macrophages and lipogranulomas throughout the spectrum of NAFLD, indicating a role for MSR1 in lipid accumulation in macrophages and concordantly inflammation ( Fig. 1c and Fig. S2 ). As 10 macrophages have been reported to regulate metabolic homeostasis in adipose tissue (14) , we evaluated MSR1 expression in subcutaneous and matched omental adipose tissue from obese patients (BMI >30 kg/m 2 ). MSR1-immunopositive macrophages were observed in crown-like structures in both types of adipose tissue, with increased levels of MSR1 in obese patients diagnosed with NAFL ( Fig. 1d and Fig. S2c ). Taken together, these human data demonstrate a 15 positive correlation of MSR1 transcript and protein levels with obesity-associated NAFLD and occurrence of hepatic-and adipose tissue-resident lipid-laden macrophages in the presence of excess lipid accumulation.
To further investigate how MSR1 functionally contributes to the development of obesityrelated NAFLD, we subjected Msr1 -/mice and their corresponding Msr1 +/+ (wild-type, WT) male 20 and age-matched counterparts to a high-fat and high-cholesterol diet (HFD) for 16 weeks. Upon HFD feeding, Msr1-deficient mice displayed an increased total body weight and an increase in liver and epididymal white adipose tissue (eWAT) weight compared to WT ( Fig. 2a-b ).
Consistently with enhanced adipose mass, HFD-fed Msr1 -/mice displayed larger adipocytes along with enhanced fatty acid accumulation within the cells and increased leptin serum levels compared 25 to WT mice, indicating an increased adiposity and fat storage in the absence of Msr1 ( Fig. 2c-d,   Fig. S3a-b ). To further test the effect of Msr1-deficiency on the metabolic syndrome, we measured several parameters within the serum as well as in the eWAT and liver tissue. HFD-fed Msr1 -/mice exhibited lower concentrations of circulating FFAs which corresponded to reduced hepatic triglycerides (TGs) and enhanced lipid utilization measured by approximately 50% higher 30 mitochondrial oxygen consumption rate in the liver compared to HFD-fed WT mice (15), while 7 circulating TG levels remained unchanged ( Fig. 2e-f, Fig. S3a-b) . Moreover, the absence of Msr1 improved glucose uptake from blood in obese mice ( Fig. S3c-e ). Although no murine models accurately recapitulate all histological features of human steatohepatitis (16) , histological and transcriptomic features of liver fibrosis were clearly attenuated by Msr1 deficiency (Fig. 2g-h) .
Specifically, less fibrosis, a hallmark of NASH development, and reduced transforming growth 5 factor beta 1 (Tgfb1) and alpha-smooth muscle actin (Acta1) expression was observed under HFD conditions compared to WT ( Fig. 2i) . Taken together, these results demonstrate that Msr1 deficiency increases the body weight but protects against HFD-associated metabolic dysregulation and liver damage. Scale bars 200µm. 10 Next we asked whether the lipid-laden environment is a proximal stimulus leading to Msr1mediated inflammation in the liver and adipose tissue, which may explain the observed metabolic dysfunction. In agreement with our human data, histopathological analysis of the liver and adipose tissue from HFD-fed Msr1 -/mice showed no hepatic lipogranuloma and hardly any foamy 15 macrophages compared to their WT counterparts, demonstrated by the F4/80 immunostaining ( Fig. 3a) . Triggering of Msr1 has recently been shown to induce JNK signaling pathway activation (8) . JNK signaling is a stress-activated pathway that has been implemented in saturated fatty acid (SFA)-induced pro-inflammatory activation of macrophages (7, 17) . Indeed, HFD-fed Msr1 -/mice exhibited reduced hepatic JNK1/2 phosphorylation compared to the WT (Fig. S4a) . Moreover, 20 Msr1 -/mice displayed lower IL-6 and TNF-ɑ serum levels and reduced Tnfa and Il6 gene expression in the liver and eWAT with increased mRNA levels of the anti-inflammatory gene Adiponectin in the eWAT ( Fig. 3b-d) (18) . Furthermore, Msr1 deficiency did not reveal a reduced presence of macrophages neither in the eWAT nor in the liver but impaired pro-inflammatory macrophage activation represented by lower gene transcripts of Tnfa and Il6 in isolated adipose 25 tissue-(ATMs) and hepatic-associated macrophages ( Fig. 3e-g) . To extend these findings, we cocultured differentiated 3T3-L1 adipocyte-like cells and lipid-fed hepatocyte-like Hepa1-6 cells indirectly with WT and Msr1 -/bone marrow-derived macrophages (BMDMs) ( Fig. S4b-d) .
Consistent with the in vivo data, Msr1 deficiency or the blocking of the Msr1 receptor using a monoclonal antibody attenuated pro-inflammatory response when co-cultured with adipocyte-like 30 cells or hepatocyte-like cells compared to WT BMDMs ( Fig. S4d-f ). Altogether, these results show that Msr1 mediates HFD-induced hepatic and adipose tissue inflammation and facilitates macrophage activation toward a pro-inflammatory phenotype. Next we investigated the underlying mechanism of Msr1-mediated lipid-induced 5 inflammation. We reasoned that Msr1 is directly responsible for lipid uptake in macrophages, leading to an inflammatory response independent from other cell types. In this regard, we measured the uptake of SFA (palmitic acid) and non-SFA (nSFA, oleic acid) in BMDMs by quantifying Oil-red-O staining using confocal microscopy. The analysis revealed that Msr1 facilitates the uptake of both SFA as well as nSFA but only SFA induced enhanced levels of Tnfa 10 and Il6 transcripts and phosphorylation of JNK signalling in WT BMDMs (Fig. 4a, Fig. S5a-c) .
Moreover, blocking of Msr1 receptor with the monoclonal antibody or the chemical inhibition of JNK signalling in macrophages abrogated the induction of Tnfa and Il6 pro-inflammatory gene expression in response to SFA treatment ( Fig. 4b-d ). Next we tested whether Msr1 mediates the pro-inflammatory gene induction in response to LPS (19) . Interestingly, Msr1-deficiency or the 15 blocking of the Msr1 receptor by monoclonal antibody did not affect the pro-inflammatory response in the presence of LPS unlike SFA, showing that Msr1 facilitates lipid-induced inflammation independent of LPS ( Fig. 4e) . Moreover, mass spectrometry-based proteomics analysis of SFA-fed (12hrs) WT and Msr1 -/-BMDMs showed enrichment in pathways including 'transport', 'lipid metabolic process' and 'phagocytosis' (Fig. S5d and Table S2 ). These data 20 indicate that Msr1 regulates JNK-mediated lipid-induced pro-inflammatory activation of macrophages independent of LPS.
Several single nucleotide polymorphisms (SNPs) have been associated with susceptibility to NAFLD (20) (21) (22) . Using a cohort of 1,483 European Caucasian patients with histologicallyproven NAFLD and 17,781 European general-population controls, we identified 4 SNPs in or 25 around the MSR1 locus with p-values<5*10 -4 , with rs41505344 as the most significant (p=1,64E-04) ( Fig. 4f and Table S3 ). Quantitative trait analysis for rs41505344 in 430,101 patients enrolled in the UKBiobank showed a significant correlation with serum triglycerides and AST levels (Table   S4 ). No effect on MSR1 expression levels in non-diseased liver (n=151) or subcutaneous adipose tissue (n=384) was observed ( Fig. S6) . Taken together, these results suggest that genetic variations 30 11 in MSR1 could modify the protein function and contribute to NAFLD susceptibility and obesityrelated diseases or even cancer (23) .
Here we show supporting evidence that the overflow of lipids during obesity provides a proximal signal for macrophages and induce inflammatory reaction in a MSR1-dependent manner.
Macrophage scavenger receptors have been reported to play an important role in the metabolic 5 homeostasis in adipose tissue (14) . In this study, we demonstrate an immunoregulatory role for MSR1 in the presence of lipids, highlighting the metabolic-inflammatory axis between the liver and adipose tissue (24, 25) . This process was shown to be independent of LPS (19) , implementing that MSR1 is crucial in the early development of obesity-induced NAFLD. 
Materials and Methods
Patient selection 10 For the histopathological and nanoString ® study, 214 liver and adipose tissue samples from EDTA, 1/50). In addition, the liver biopsies were immunostained with monoclonal mouse antihuman CD68 antibody (clone KP1; Dako; EDTA, ready-to-use). Envision Flex+ reagent (Dako) was used as secondary antibody at room temperature and 3',3'-diaminobenzidine for the 15 visualization step. Immunopositive cells in the liver biopsies were quantified in the parenchyma and the portal tract as previously reported (2) .
Animals
Msr1 -/mice were kindly provided by Prof. Siamon Gordon, University of Oxford. All mice were 20 maintained under specific pathogen free conditions and experiments were approved by the Institutional Animal Care and Use Committee. Mice had free access to water and were fed either standard chow or high-fat and high-cholesterol diets (45%-HFD; 820263,Special Diet Services) ad libitum. Body weight was measured weekly during the feeding period and compared with liver weight and visceral fat mass after the animals were sacrificed. On the day prior to sacrifice, the 25 mice were subjected to overnight fasting.
Glucose tolerance test (GTT)
To assess glucose tolerance, 8-week-old mice were fed a standard chow or a 45% high-fat diet for 16 weeks. Mice were injected intraperitoneally with 2 g glucose/kg body weight after overnight 30 14 fasting for GTT assay. Tail-blood glucose levels were measured by using an ACCU-CHEK Aviva (Roche) glucometer.
Bioenergetics
Tissue bioenergetics was determined using a Seahorse respirometer as previously described (15) . 5 Briefly, WAT and liver were collected rapidly after sacrifice, and rinsed with Krebs-Henseleit buffer (KHB) (111mM NaCl, 4.7mM KCl, 2mM MgSO4, 1.2mM Na2HPO4, 0.5mM carnitine, 2.5mM glucose and 10mM sodium pyruvate). Tissues were cut into small pieces (6-10mg) and quickly transferred to individual wells of a XF24 plate. Individual pieces were stabilized from excessive movement by isletcapture screens (Seahorse Bioscience), and 450μL KHB was added 10 to each well. Digitonin was added to enhance plasma membrane permeability. Basal oxygen consumption rates (OCR) were determined according to the following plan: Basal readings recorded every 2min for 10 readings, followed by exposure to digitonin. Subsequent readings were recorded after 2min mixing and 2min rest. Basal OCR values were normalized to individual tissue weights. 15 
Blood biochemical analysis
Blood samples were obtained from the heart by cardiac puncture, and serum samples were preserved at −80 °C for biochemical analyses as described below. The total triglycerides (TG), free fatty acids (FFA) levels were determined using the fluorometric method using the commercial 20 available kit from Abcam (ab178780) and (ab65341). The serum Leptin was measured using an ELISA (Quantikine, RD systems). The serum TNF- and IL-6 were measured using an ELISA (DuoSet Elisa, RD systems). 25 The liver TG and eWAT fatty acids concentrations were determined using the fluorometric method using the commercial available kit from Abcam (ab178780) and (ab65341).
Assessments of hepatic TGs and eWAT FAs

Immunohistochemistry and analysis of mouse tissue sections
Histology was performed on WAT and liver following fixation in 10% formalin for 24 hr, 30 dehydration, and embedding in paraffin. Sections (5 μm) were cut and stained using hematoxylin 15 and eosin (H&E). Mouse tissue samples were immunostained with rat monoclonal anti-F4/80 antibody (ab6640; Abcam, Cambridge, UK; citrate 1/50) and a Goat Anti-Rat IgG H&L (ab97057;
Abcam; 1/100), followed by 3',3'-diaminobenzidine for the visualization. Histopathological scoring of the liver samples was based on the semiquantitative NASH-CRN Scoring System (NAS). In addition, sinusoidal fibrosis was scored as 0=absent, 1=mild, 2=moderate, 3=prominent. 5 Cell size of the adipose tissue was quantified based on a haematoxylin & eosin staining using Nikon NIS elements software.
Adipose-tissue and liver-associated macrophages isolations
Digested epididymal fat pads and liver passed through either a 100-μm or 70--μm filters (BD, 10 falcon) and spun at 300g for 5 min. Thereafter, adipose tissue macrophages were enriched using magnetic immunoaffinity isolation with anti-F4/80 + antibodies conjugated to magnetic beads (MACS; Miltenyi Biotec, Auburn, CA) and the liver associated macrophages were obtained by the isotonic 33% Percoll (Sigma-Aldrich) solution method. 15 Cell culture and stimulation Aldrich) conjugated to fatty acid-depleted BSA for 6, 12h or 24 hrs. Cells were fixed with 10% formaldehyde for 10 min and stained with a 60% Oil Red O/isopropanol solution (Sigma-Aldrich).
The slides were analyzed using the Leica TCS SP8 confocal microscope platform (Leica Biosystems). 5 
Immunoblot analysis
Liver lysates were separated by SDS-PAGE and transferred to Immobilon-P PVDF membranes (Millipore). After blocking with 5% nonfat dry milk in Tris-buffered saline and 0.1% Tween (TBS-T), the membranes were incubated with the indicated antibodies overnight at 4°C. After 2hr incubation with the appropriate horseradish peroxidase-conjugated antibodies, the immune The following validated QuantiTect primer assays (Qiagen) were used: Tnfa and Il6. 20 
Primer name
Forward Reverse
Flow cytometry
Following treatment, WT and Msr1 -/-BMDMs were stained with FcBlock (BD) followed by pJNK1/2 (#5755, Cell Signaling) staining according to manufacturer's protocol and analysed using a BD Facs Canto cytometer (BD Biosciences). Data were processed using FlowJo Software v10. 5 Mass spectrometry analysis Label-free mass spectrometry acquisition 20 Peptide samples were separated on an Ultimate 3000 RSLC system (Thermo Scientific) with a C18 PepMap, serving as a trapping column (2 cm x 100 µm ID, PepMap C18, 5 µm particles, 100 Å pore size) followed by a 50 cm EASY-Spray column (50 cm x 75 µm ID, PepMap C18, 2 µm particles, 100 Åpore size) (Thermo Scientific). Buffer A contained 0.1% FA and Buffer B 80% ACN, 0.1% FA. Peptideswere separated with a linear gradient of 1-35% (Buffer B) over 120 25 minutes followed by a step from 35-90% ACN, 0.1% FA in 0.5 minutes at 300 nL/min and held at 90% for 4 minutes. The gradient wasthen decreased to 1% Buffer B in 0.5 minutes at 300 nL/min for 10 minutes. Mass spectrometric identification was performed on an Orbitrap QE HF mass spectrometer (Thermo Scientific) operated "Top Speed" data dependant mode in positive ion mode. FullScan spectra were acquired in a range from 400 m/z to 1500 m/z, at a resolution of 120 30 000 (at 200 m/z), with an automated gain control (AGC) of 1,000,000 and a maximum injection 18 time of 50 ms. Charge state screening is enabled to exclude precursors with a charge state of 1.
For MS/MS fragmentation, the minimum AGC was set to 5000 and the most intense precursor ions were isolated with a quadrupole mass filter width of 1.6 m/z and 0.5 m/z offset. Precursors were subjected to CID fragmentation that was performed in one-step collision energy of 25%.
MS/MS fragments ions were analysed in the Orbitrap mass analyser with a 15 000 resolution at 5 200 m/z.
Mass spectrometry data analysis
Protein identification and label free quantification was performed using MaxQuant Version Quantification was performed using razor and unique peptides, and required a minimum count of 15 2. "Re-quantify" and "match between runs" were enabled. LFQ intensities were extracted for each protein/condition and used for downstream analyses. Statistical analyses were performed in Perseus (v1.6.6.0). T-test-based statistics were applied on LFQ intensity values to extract the significant regulated proteins. DAVID annotation tool was used for pathway enrichment. (3, 4) Data were visualized with GOPlot (7, 8) . For the present study, we restricted our analysis to a subset of UK Biobank participants with European ancestry by adding individuals who self-reported as being 'Irish' or 'Any other white background' (after removal of outliers based on first 2 genetic principal components) to the subset 10 of white British ancestry (7, 9) . We then excluded individuals with (1) excessive relatives (more than 10 putative third-degree relatives); (2) a mismatch between the self-reported and genetically (Portal hypertension), or I85 (13) . Details of the genotyping and imputation procedures in the UK Biobank have been previously described (7) . Briefly, UK Biobank participants were genotyped 20 using two similar arrays: the UK BiLEVE or UK Biobank Axiom array. Genotyped data were then imputed based on the 1000 Genomes Phase 3, UK10K haplotype, and Haplotype Reference Consortium (HRC) reference panels (7) . For MSR1 rs41505344, we used UKB version 3 of imputed genotype data (info score = 0.98) and converted imputed genotype probabilities to hard genotype calls using PLINK 2 (14) . The associations between liver cirrhosis and MSR1 25 rs41505344 was examined using binary logistic regression adjusted for age, gender, BMI, the first ten genomic principal components, the array type and the assessment center. Continuous traits were first rank-based inverse normal transformed, and their association with rs41505344 was then examined using linear regression adjusted for the abovementioned covariates. All analyses were performed under an additive genetic model. 
